Development of a new reporter gene system-dsRed/Xanthine phosphoribosyltransferase-xanthine for molecular imaging of processes behind the intact blood-brain barrier

Molecular Imaging

Volumn 2, Issue 2, 2003, Pages 93-112

  Doubrovin, Mikhail ^a   Ponomarev, Vladimir ^a   Serganova, Inna ^a   Soghomonian, Suren ^a   Myagawa, Tadashi ^a   Beresten, Tatiana ^a   Ageyeva, Lyudmila ^a   Sadelain, Michel ^a   Koutcher, Jason ^a   Blasberg, Ronald G ^a   Gelovani Tjuvajev, Juri G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Blood brain barrier; dsRed; Molecular imaging; Santhine phosphoribotransferase

Indexed keywords

BLOOD; BRAIN; CELLS; ENZYME IMMOBILIZATION; ESCHERICHIA COLI; FLUORESCENCE; GENES; HYDROPHILICITY; ORGANIC COMPOUNDS; PROTEINS; RADIOACTIVE TRACERS; TUMORS;

GLIOBLASTOMA MULTIFORME; MOLECULAR IMAGING; NUCLEAR IMAGING; XANTHINE PHOSPHORIBOSYLTRANSFERASE;

MEDICAL IMAGING;

FLUORESCENT PROTEIN 583; GLYCOSYLTRANSFERASE; PHOTOPROTEIN; RED FLUORESCENT PROTEIN; XANTHINE; XANTHINE DERIVATIVE; XANTHINE PHOSPHORIBOSYLTRANSFERASE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; BRAIN TUMOR; CANCER TRANSPLANTATION; CELL CULTURE; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; DIMERIZATION; DOSE RESPONSE; ESCHERICHIA COLI; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; KINETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; MUSCLE; NUDE MOUSE; PHOSPHORYLATION; RAT; REPORTER GENE; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION; TIME;

AMINO ACID SEQUENCE; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN NEOPLASMS; DIMERIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; GENES, REPORTER; KINETICS; LUMINESCENT PROTEINS; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; MODELS, CHEMICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUSCLES; NEOPLASM TRANSPLANTATION; PENTOSYLTRANSFERASES; PHOSPHORYLATION; RATS; SEQUENCE HOMOLOGY, AMINO ACID; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; XANTHINE; XANTHINES;

EID: 0042475156     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.1162/153535003322331984     Document Type: Article

References (101)

1. Tjuvajev JG, Stockhammer G, Desai R, Uehara H, Watanabe K, Gansbacher B, Blasberg R.G. (1995) Imaging the expression of transfected genes in vivo. Cancer Res. 55:6126-6132.
2. Doubrovin M, Ponomarev V, Beresten T, Balatoni J, Bornmann W, Finn R, Humm J, Larson S, Sadelain M, Blasberg R, Gelovani Tjuvajev J (2001) Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. Proc Natl Acad Sci USA. 98:9300-9305.
3. Ponomarev V, Doubrovin M, Lyddane C, Beresten T, Balatoni J, Bornman W, Finn R, Akhurst T, Larson S, Blasberg R, Sadelain M, Tjuvajev JG (2001) Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo. Neoplasia. 3:480-488.
4. Lyden D, Hattori K, Dias S, Costa C, Blaike P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA, Manova K, Benezra R, Rafii S (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med. 7:1194-1201.
5. Adams JY, Johnson M, Sato M, Berger F, Gambhir SS, Carey M, Arispe I, ML, Wu L (2002). Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optimal imaging. Nat Med. 8:891-897.
6. Sweeney T, Mailander V, Tucker A, Olomu AB, Zhang W, Negrin RS, Contag CH (1999) Visualizing tumor cell clearance in living animals. Proc Natl Acad Sd USA. 96:12044-12049.
7. Wu GD, Nolta JA, Jin YS, Barr ML, Yu H, Starnes VA, Cramer DV (2003). Migration of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation. 75:679-685.
8. Koehne G, Doubrovin M, Doubrovina E, Zanzonico P, Gallardo HF, Ivanova A, Balatoni J, Teruya-Feldstein J, Heller G, May C, Ponomarev V, Ruan S, Finn R, Blasberg RG, Bornmann W, Riviere I, Sadelain M, O'Reilly RJ, Larson SM, Tjuvajev JG (2003). Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes. Nat Biotechnol. 21:405-413.
9. Miyagawa T, Oku T, Uehara H, Desai R, Beattie B, Tjuvajev J, Blasberg R (1998) "Facilitated" amino acid transport is upregulated in brain tumors. J Cereb Blood Flow Metab. 18:500-509.
10. Abraham MH, Ibrahim A, Zissimos AM, Zhao YH, Comer J, Reynolds DP (2002) Application of hydrogen bonding calculations in property based drug design. Drug Discov Today. 7:1056-1063.
11. Gratton JA, Abraham MH, Bradbury MW, Chadha HS (1997) Molecular factors influencing drug transfer across the blood-brain barrier. J Pharm Pharmacol. 49:1211-1216.
12. Joborn C, Hetta J, Niklasson F, Rastad J, Wide L, Agren H, Akerstrom G, Ljunghall S (1991) Cerebrospinal fluid calcium, parathyroid hormone, and monoamine and purine metabolites and the blood-brain barrier function in primary hyperparathyroidism. Psychoneuroendocrinology. 16:311-322.
13. Tovi M, Lilja A, Bergstrom M, Ericson A, Bergstrom K, Hartman M (1990) Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography. Acta Radiol. 31:417-429.
14. Asari S, Makabe T, Katayama S, Itoh T, Tsuchida S, Ohmoto T (1994). Assessment of the pathological grade of astrocytic gliomas using an MRI score. Neuroradiology. 36:308-310.
15. Tovi M, Hartman M, Lilja A, Ericsson A (1994). MR imaging in cerebral gliomas. Tissue component analysis in correlation with histopathology of whole-brain specimens. Acta Radiol. 35:495-505.
16. Iyer M, Barrio JR, Namavari M, Bauer E, Satyamurthy N, Nguyen K, Toyokuni T, Phelps ME, Herschman HR, Gambhir SS (2001). 8-[18F]Fluoropenciclovir: An improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET. J Nucl Med. 42:96-105.
17. MacLaren DC, Gambhir SS, Satyamurthy N, Barrio JR, Sharfstein S, Toyokuni T, Wu L, Berk AJ, Cherry SR, Phelps ME, Herschman HR (1999) Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther. 6:785-791.
18. Greig NH (1992). Drug entry into the brain and its pharmacologic manipulation. In: Bradbury MWB, ed. Physiology and pharmacology of the blood-brain barrier, Handbook of experimental pharmacology. Vol. 103. Berlin: Springer-Verlag. pp. 489-523.
19. Greig NH, Yu QS, Utsuki T, Holloway HW, Zhu X, Perry T, Lee BH, Ingram DK, Lahiri DK (2000). Optimizing drugs for brain action. In: Kobler D, Lustig S, Shapira S. eds. Blood-brain barrier, drug delivery and brain pathology. New York: Kluwer Academic/Plenum. pp. 281-309.
20. Tanaka H, Mizojiri K (1999) Drug-protein binding and blood-brain barrier permeability. J Pharmacol Exp Ther. 288:912-918.
21. Ghei M, Mihailescu M, Levinson D (2002) Pathogenesis of hyperuricemia: Recent advances [Review]. Curr Rheumatol Rep. 4:270-274.
22. Lopez Jimenez M, Garcia Puig J, Mateos Anton F, Ramos Hernandez T, Pascual Castroviejo I, Ortiz Vazquez J (1989) Purine transport through the blood-brain barrier in hypoxanthine phosphoribosyltransferase deficiency. Med Clin (Barc). 92:167-170.
23. Buhrdel P, Kruger W, Hirschberg K, Wehnert M (1985) Adenine therapy in Lesch-Nyhan syndrome. Acta Paediatr Hung. 26:327-333.
24. Groothuis DR, Pasternak JF, Fischer JM, Blasberg RG, Bigner DD, Vick NA (1983) Regional measurements of blood flow in experimental RG-2 rat gliomas. Cancer Res. 43:3362-3367.
25. Nakagawa H, Groothuis DR, Owens ES, Fenstermacher JD, Patlak CS, Blasberg RG (1987). Dexamethasone effects on [125I]albumin distribution in experimental RG-2 gliomas and adjacent brain. J Cereb Blood Flow Metab. 7:687-701.
26. Peters C, Braun M, Weber B, Wendland M, Schmidt B, Pohlmann R, Waheed A, von Figura K (1990). Targeting of a lysosomal membrane protein: A tyrosine-containing endocytosis signal in the cytoplasmic tail of lysosomal acid phosphatase is necessary and sufficient for targeting to lysosomes. EMBO J. 9:3497-3506.
27. Naim HY, Lacey SW, Sambrook JF, Gething MJ (1991). Expression of a full-length cDNA coding for human intestinal lactase-phlorizin hydrolase reveals an uncleaved, enzymatically active, and transport-competent protein. J Biol Chem. 266: 12313-12320.
28. Riviere I, Brose K, Mulligan RC (1995) Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci USA. 92:6733-6737.
29. Davson J, Danielli JF (1943) The permeability of natural membranes. Cambridge: Cambridge University Press.
30. Fenstermacher JD (1983) Drug transfer across the blood brain barrier. In: Breimer DD, Speiser P. eds. Topics in pharmaceutical sciences. Amsterdam: Elsevier. pp. 143-154.
31. Fenstermacher JD, Rapoport SI (1984). Blood-brain barrier. In: Handbook of physiology. The cardiovascular system. Microcirculation. Vol. IV. Bethesda, MD: Am, Physiol. Soc. pp. 969-1000.
32. Fenstermacher, JD (1988). The pharmacology of the blood-brain barrier. In: Neuwelt E. ed. Implications of the blood-brain barrier and its manipulation. Basic science aspect. Vol. 1. New York: Plenum. pp. 132-155.
33. Sakurada O, Kennedy C, Jehle J, Brown J, Carbin GL, Sokoloff L (1978). Measurement of local cerebral blood flow with iodo(14 C)iodoantipyrine. Am J Physiol. 234:H59-H66.
34. Jay T, Lucignani G, Crane A, Jehle J, Sokoloff L (1988) Measurement of local cerebral blood flow with [14C]iodoantipyrine in the mouse. J Cereb Blood Flow Metab. 8:121-129.
35. Hossman KA, Bloink M (1981). Blood flow and regulation of blood flow in experimental peritumoral edema. Stroke. 12: 211-217.
36. Maeda K, Mies G, Olah L, Hossmann KA (2000) Quantitative measurement of local cerebral blood flow in the anesthesized mouse using intraperitoneal [14C]iodoantipyrine injection and final arterial heart blood sampling. J Cereb Blood Flow Metab. 20:10-14.
37. Ohno K, Pettigrew KD, Rapoport SI (1979). Local cerebral blood flow in the conscious rat as measured with 14C-antipyrine, 14C-iodoantipyrine and 3H-nicotine. Stroke. 10:62-67.
38. Jacobs A, Dubrovin M, Hewett J, Sena-Estives M, Cui-Wen Tan, Slack M, Sadelain M, Breakfield X, Tjuvajev J (1999). Functional co-expression of HSV-1 thymidine kinase and green fluorescent protein: Implications for noninvasive imaging of transgene expression. Neoplasia. 1:154-162.
39. Tjuvajev J, Kolesnikov Y, Joshi R, Sherinski J, Koutcher L, Zhou Y, Matei C, Koutcher J, Kreek MJ, Blasberg R (1998). Anti-neoplastic properties of human corticotropin releasing factor: Involvement of nitric oxide pathway. In Vivo. 12:1-9.
40. Baird GS, Zacharias DA, Tsien RY (2000) Biochemistry, mutagenesis, and oligomerization of DsRed, a red fluorescent protein from coral. Proc Natl Acad Sci USA. 97:11984-11989.
41. Campbell RE, Tour O, Palmer AE, Steinbach PA, Baird GS, Zacharias DA, Tsien RY (2002). A monomeric red fluorescent protein. Proc Natl Acad Sci USA. 99:7877-7882.
42. Jacobs AH, Winkeler A, Hartung M, Slack M, Dittmar C, Kummer C, Knoess C, Galldiks N, Vollmar S, Wienhard K, Heiss WD (2003). Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes. Hum Gene Ther. 14:277-297.
43. Ponomarev V, Doubrovin M, Serganova I, Beresten T, Vider J, Shavrin A, Ageyeva L, Balatoni J, Blasberg R, Gelovani Tjuvajev JG. Cytoplasmically retargeted HSV1-tk/GFP reporter gene mutants for optimization of non-invasive molecular-genetic imaging. Neoplasia (in press).
44. Mulligan RC, Berg P (1981). Selection of animal cells that express the Escherichia coli gene encoding for xanthine-guanine phosphoribosyltransferase. Proc Natl Acad Sci USA. 78:2072-2076.
45. Mroz PJ, Moolten FL (1993). Retrovirally transduced Escherichea coli gpt genes combine selectability with chemosensitivity capable of mediating tumor eradication. Human Gene Ther. 4:589-595.
46. Natsumeda Y, Prajda N, Donohue JP, Glover JL, Weber G (1984). Enzymic capacities of purine de Novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues. Cancer Res. 44:2475-2479.
47. Allsop J, Watts RW (1980). Activities of amidophosphoribosyltransferase (EC2.4.2.14) and the purine phosphoribosyltransferases (EC2.4.2.7 and 2.4.2.8), and the phosphoribosylpyrophosphate content of rat central nervous system at different stages of development-their possible relationship to the neurological dysfunction in the Lesch-Nyhan syndrome. J Neurol Sci. 46:221-232.
48. Zimmerman AL, Yamanaka G, Eckstein F, Baylor DA, Stryer L (1985). Interaction of hydrolysis-resistant analogs of cyclic GMP with the phosphodiesterase and light-sensitive channel of retinal rod outer segments. Proc Natl Acad Sci USA. 82:8813-8817.
49. Patlak CS, Blasberg RG, Fenstermacher JD (1983). Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 3:1-7.
50. Bianchi G, Caccia S, Della Vedova F, Garattini S (1989). Kinetics and brain uptake of S 9795, a new xanthine derivate, in rats. Eur J Drug Metab Pharmacokinet. 14:201-208.
51. Springer RH, Dimmitt MK, Novinson T, O'Brien DE, Robins RK, Simon LN, Miller JP (1976). Synthesis and enzymic activity of some novel xanthine oxidase inhibitors. 3-Substituted 5,7-dihydroxypyrazolo(1,5-alpha)pyrimidines. J Med Chem. 19:291-296.
52. Hackman T, Doubrovin M, Balatoni J, Beresten T, Ponomarev V, Beattie B, Finn R, Bornmann W, Blasberg R, Gelovani Tjuvajev JG (2002). Imaging expression of cytosine deaminase-herpes virus thymidine kinase fusion gene (CD/TK) expression with [124I]FIAU and PET. Mol Imaging. 1:36-42.
53. Tjuvajev JG, Doubrovin M, Akhurst T, Cai S, Balatoni J, Alauddin MM, Finn R, Bornmann W, Thaler H, Conti PS, Blasberg RG (2002). Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J Nucl Med. 43:1072-1083.
54. Iyer M, Barrio JR, Namavari M, Bauer E, Satyamurthy N, Nguyen K, Toyokuni T, Phelps ME, Herschman HR, Gambhir SS (2001). 8-[18F] Fluoropenciclovir: An improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET. J Nucl Med. 42:96-105.
55. Alauddin NM, Shahinian A, Kundu RK, Gordon EM, Conti PS (1999). Evaluation of 9-[(3-18F-fluoro-1-hydroxy-2-propoxy)-methyl]guanine ([18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors. Nucl Med Biol. 26:371-376.
56. Gambhir SS, Barrio JR, Phelps ME, Iyer M, Namavari M, Satyamurthy N, Wu L, Green LA, Bauer E, MacLaren DC, Nguyen K, Berk AJ, Cherry SR, Herschman HR (1999). Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci USA. 96:2333-2338.
57. Saito Y, Rubenstein R, Price RW, Fox JJ, Watanabe KA (1984). Diagnostic imaging of herpes simplex virus encephalitis using a radiolabeled antiviral drug: Autoradiographic assessment in an animal model. Ann Neurol. 15:548-558.
58. Cornford EM, Oldendorf WH (1975). Independent blood-brain barrier transport systems for nucleic acid precursors. Biochim Biophys Acta. 394:211-219.
59. Wu D, Clement JG, Pardridge WM (1998). Low blood-brain barrier permeability to azidothymidine (AZT), 3TC, and thymidine in the rat. Brain Res. 791:313-316.
60. Tjuvajev J, Muraki A, Ginos J, Berk J, Koutcher J, Ballon D, Beattie B, Finn R, Dahighian F, Blasberg R (1993). Iododeoxyuridine uptake and retention as a measure of tumor growth. J Nucl Med. 34:1152-1162.
61. Tjuvajev JG, Macapinlac HA, Daghighian F, Scott AM, Ginos JZ, Finn RD, Kothari P, Desai R, Zhang J, Beattie B, et al. (1994). Imaging of brain tumor proliferative activity with iodine-131-iododeoxyuridine. J Nucl Med. 35:1407-1417.
62. Jacobs A, Voges J, Reszka R, Lercher M, Gossmann A, Kracht L, Kaestle C, Wagner R, Wienhard K, Heiss WD (2001). Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet. 358:727-729.
63. MacLaren DC, Gambhir SS, Satyamurthy N, Barrio JR, Sharfstein S, Toyokuni T, Wu L, Berk AJ, Cherry SR, Phelps ME, Herschman HR (1999). Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther. 6:785-791.
64. Liang Q, Satyamurthy N, Barrio JR, Toyokuni T, Phelps MP, Gambhir SS, Herschman HR (2001). Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transduction. Gene Ther. 8:1490-1498.
65. Rogers BE, McLean SF, Kirkman RL, Manna DD, Bright SJ, Olsen CC, Myracle AD, Mayo MS, Curiel DT, Buchsbaum DJ (1999). In vivo localization of [(111)In]-DTPA-D-Phe1-octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vector. Clin Cancer Res. 5:383-393.
66. Rogers BE, Zinn KR, Buchsbaum DJ (2000). Gene transfer strategies for improving radiolabeled peptide imaging and therapy. Q J Nucl Med. 44:208-223.
67. Barrio JB, Satyamurthy N, Huang S-C, Keen R, Nissenson CHK, Hoffman JM, Ackermann RF, Bahn MM, Mazziotta JC, Phelps ME (1989). 3-(2'-[18F]fluoroethyl)spiperone: In vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans. J Cereb Blood Flow Metab. 9:830-839.
68. Ur E, Bomanji J, Mather SJ, Britton KE, Wass JA, Grossman AB, Besser GM (1993). Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide. Clin Endocrinol. (Oxf) 38:501-506.
69. Banks WA, Schally AV, Barrera CM, Fasold MB, Durham DA, Csernus VJ, Groot K, Kastin AJ (1990). Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin. Proc Natl Acad Sci USA. 87:6762-6766.
70. Haldemann AR, Rosler H, Barth A, Waser B, Geiger I, Godoy N, Markwalder RV, Seiler RW, Sulzer M, Reubi JC (1995). Somatostatin receptor scintigraphy in central nervous system tumors: Role of blood-brain barrier permeability. J Nucl Med. 36:403-410.
71. Jaehde U, Masereeuw R, De Boer AG, Fricker G, Nagelkerke JF, Vonderscher J, Breimer DD (1994). Quantification and visualization of the transport of octreotide, a somatostatin analogue, across monolayers of cerebrovascular endothelial Pharm Res. 11:442.
72. Fricker G, Nobmann S, Miller DS (2002). Permeability of porcine blood brain barrier to somatostatin analogues. Br J Pharmacol. 135:1308-1314.
73. Edinger M, Sweeney TJ, Tucker AA, Adesuwa B, Olomu AB, Negrin RS, Contag CH (1999). Non-invasive assessment of tumor cell proliferation in animal models. Neoplasia. 1:303-310.
74. Rehemtulla A, Stegman LD, Cardozo SJ, Gupta S, Hall DE, Contag CH, Ross BD (2000). Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia. 6:491-495.
75. Rehemtulla A, Hall DE, Stegman LD, Chen G, Bhojani MS, Chenevert TL, Ross BD (2002). Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor. Gene Therapy. 1:43-55.
76. Contag PR, Olomu IN, Stevenson DK, Contag CH (1998). Bioluminescent indicators in living mammals. Nat Med. 4:245-247.
77. Contag C, Spilman S, Contag P, Oshiro M, Eames B, Dennery P, Stevenson O, Benaron D (1997). Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol. 66:523-531.
78. Chishima T, Yang M, Miyagi Y, Li L, Tan Y, Baranov E, Shimada H, Moossa AR, Penman S, Hoffman RM (1997). Governing step of metastasis visualized in vitro. Proc Natl Acad Sci USA. 94:11573-11576.
79. Chishima T, Miyagi Y, Wang X, Tan Y, Shimada H, Moossa A, Hoffman RM (1997). Visualization of the metastatic process by green fluorescent protein expression. Anticancer Res. 17:2377-2384.
80. Day RN, Kawecki M, Berry D (1998). Dual function reporter protein for analysis of gene expression in living cells. Biotechnology. 25:848-850.
81. Bhaumik S, Gambhir SS (2002). Optical imaging of Renilla luciferase reporter gene expression in living cells. Proc Natl Acad Sci USA. 1:377-382.
82. Wu JC, Inubushi M, Sundaresan G, Schelbert HR, Gambhir SS (2002). Optical imaging of cardiac reporter gene expression in living rats. Circulation. 14:1631-1634.
83. Serganova I, Doubrovin M, Ponomarev V, Beresten T, Ageyeva L, Vider J, Soghomonian S, Balatoni J, Finn R, Blasberg R, Gelovani Tjuvajev J. (2002). PET Imaging of Hypoxia-Induced (HIF-1α) Signaling In Vivo. ASGT 2002 abstract no. 1287.
84. Serganova I, Ponomarev V, Ageyeva L, Doubrovin M, Balatoni J, Finn R, Blasberg R, Gelovani Tjuvajev J (2003). Imaging of PI3K-Akt-Forkhead Transcription Factor Signal Transduction Pathway Activity. SNM 3003 abstract.
85. Kelley WN, Rosenbloom FM, Henderson JF, Seegmiller JE (1967). Xanthine phosphoribosyl-transferase in man: Relationship to hypoxanthine-guanine phosphoribosyltransferase. Biochem Biophys Res Commun. 28:340-345.
86. Krenitsky TA, Papaioannou R, Elion GB (1969). Human hypoxanthine-guanine phosphoribosyl-transferase: Purification, properties and specificity. J Biol Chem. 244:1263-1270.
87. Reyes P, Rathod PK, Sanchez DJ, Mrema JEK, Rieckmann KH, Hiedrich H-G (1982). Enzymes of purine and pyrimidine metabolism from the human malaria parasite, Plasmodium falciparum. Mol Biochem Parasitol. 5:275-290.
88. Eads JC, Scapin G, Xu Y, Grubmeyer C, Sacchettini JC (1994). The crystal structure of human hypoxanthine-guanine phosphoribosyltransferase with bound GMP. Cell. 78:325-334.
89. Somoza JR, Chin MS, Focia PJ, Wang CC, Fletterick RJ (1996). Crystal structure of the hypoxanthine-guanine-xanthine phosphoribosyltransferase from the protozoan parasite Tritrichomonas foetus. Biochemistry. 35:7032-7040.
90. Schumacher MA, Carter D, Ross DS, Ulman B, Brennan RG (1996). Nat Struct Biol. 3:881-887.
91. Vos S, de Jersey J, Martin JL (1997). Crystal structure of Escherichia coli xanthine phosphoribosyl-transferase. Biochemistry. 36:4125-4134.
92. Vos S, Parry RJ, Burns MR, de Jersey J, Martin JL (1998). Structures of free and complexed forms of Escherichia coli xanthine-guanine phosphoribosyltransferase. J Mol Biol. 282:875-889.
93. Naguib FNM, Iltzsch MH, El Kouni MM, Panzica RP, El Kouni MH (1995). Structure-specificity relationships for the binding of ligands to xanthine or guanine phosphoribosyltransferase from Toxoplasma gondii. Biochem Pharmacol. 50:1685-1693.
94. Barrio JR, Namavari M, Phelps ME, Satyamurthy N (1996). Elemental fluorine to 8-fluoropurines in one step. J Am Chem Soc. 118:10408-10411.
95. Barrio JR, Namavari M, Keen RE, Satyamurthy N (1998). The elusive 8-fluoroadenosine. Tetrahedron Lett. 39:7231-7234.
96. Parks DA, Granger DN (1986). Xanthine oxidase: Biochemistry, distribution and physiology. Acta Physiol Scand Suppl. 548:87-99.
97. Hille R, Stewart RC (1984). The inhibition of xanthine oxidase by 8-bromoxanthine. J Biol Chem. 259:1570-1576.
98. Scott JT, Hall AP, Grahame R (1966). Allopurinol in treatment of gout. Br Med J. 509:321-327.
99. Axelsson KL, Karlsson JO, Pettersson G (1995). Effect of glyceryltrinitrate and 8-Br-cGMP on tension and phosphorylase a activity in vascular smooth muscle. Acta Pharmacol Toxicol (Copenh). 57:227-233.
100. Hagen V, Dzeja C, Frings S, Bendig J, Krause E, Kaupp UB (1996). Caged compounds of hydrolysis-resistant analogues of cAMP and cGMP: Synthesis and application to cyclic nucleotide-gated channels. Biochemistry. 35:7762-7771.
101. Bomboy JD Jr., Salmon WD Jr. (1980). Effects of cyclic nucleotides on deoxyribonucleic acid synthesis in hypophysectomized rat cartilage: Stimulation of thymidine incorporation and potentiation of the action of somatomedin by analogs of adenosine 3′,5′-monophosphate or a cyclic nucleotide phosphodiesterase inhibitor. Endocrinology. 107:626-632.